معرفی
Michael Grant, MD, serves as an Assistant Professor of Medicine specializing in Medical Oncology at Yale School of Medicine. He is affiliated with the Department of Medical Oncology and Hematology, Yale Cancer Center, and provides clinical care for patients with thoracic and genitourinary malignancies. His work bridges clinical practice with translational research, focusing on advancing personalized cancer treatments.
Dr. Grant's educational background includes:
- MD from Albert Einstein College of Medicine (2016)
- Residency in Internal Medicine at Duke University School of Medicine (2019)
- BS in Biology/Mathematics from Dickinson College (2011)
His research interests center on targeted and immunotherapy approaches to non-small cell lung cancer (NSCLC), with particular focus on EGFR-targeted therapies, drug resistance mechanisms, circulating tumor DNA, and biomarker development. Dr. Grant emphasizes personalized care by leveraging molecular features of a patient's cancer to select optimal treatments, stating that 'comprehensively testing for all available biomarkers so that each treatment decision is maximally informed' is crucial to his practice philosophy.
His publication record shows a strong focus on NSCLC treatment, particularly immunotherapy responses and EGFR-targeted therapy resistance. Notably, he has also contributed significantly to consensus guidelines in perioperative care, anesthesiology, and cardiology, demonstrating interdisciplinary collaboration across medical specialties. His work spans both clinical oncology research and broader surgical/anesthesiology applications.
- ASCO Conquer Cancer Young Investigator Award (2021) for studying sensitivity and resistance to EGFR-targeted therapies in NSCLC patients
Dr. Grant collaborates extensively with leading researchers including Sarah Goldberg, Wanda Popescu, Katerina Politi, Paul Stockhammer, Anna Wurtz, and Scott Gettinger. His research is supported by the Yale Cancer Center T32 Advanced Training Program for Physician-Scientists, which funds fellows committed to independent physician-scientist careers in cancer research. His clinical work focuses on providing personalized care that integrates the latest advances in molecular oncology with compassionate patient relationships.
Dr. Grant is actively involved in multiple research teams including the Yale Cancer Center, Center for Thoracic Cancers, and Cancer Signaling Networks. His interdisciplinary approach connects oncology with anesthesiology, cardiology, and surgical specialties, reflecting the increasingly integrated nature of modern cancer care and research.